You can find the annual or quarterly income statement of 60 Degrees Pharmaceuticals Inc here for insights into the performance and operational efficiency of 60 Degrees Pharmaceuticals Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

Total revenue

256.87%528.56K

144.93%307.87K

75.42%256.28K

512.17%261.44K

16.85%148.11K

100.64%125.70K

580.65%146.09K

--42.71K

-60.20%126.75K

67.36%62.65K

-86.93%21.46K

--318.45K

--37.43K

--164.17K

--286.64K

Revenue

256.87%528.56K

144.93%307.87K

75.42%256.28K

512.17%261.44K

16.85%148.11K

100.64%125.70K

580.65%146.09K

--42.71K

-60.20%126.75K

67.36%62.65K

-86.93%21.46K

--318.45K

--37.43K

--164.17K

--286.64K

Cost of revenue

381.43%537.69K

-44.12%50.05K

11.97%73.27K

-19.27%118.08K

56.87%111.69K

-51.32%89.56K

-10.51%65.44K

--146.26K

-22.85%71.20K

111.18%183.98K

-18.88%73.12K

--92.28K

--87.12K

--90.13K

--71.62K

Operating expenses

25.91%2.85M

-55.67%1.91M

46.65%2.17M

20.67%2.34M

37.51%2.27M

407.20%4.31M

52.01%1.48M

--1.94M

208.96%1.65M

17.44%850.64K

196.49%972.13K

--533.56K

--724.35K

--327.88K

--768.53K

R&D expenses

-13.86%809.78K

-91.93%249.88K

20.89%407.62K

512.72%613.96K

256.49%940.06K

1418.27%3.10M

171.93%337.18K

--100.20K

853.55%263.70K

-11.89%203.87K

96.64%123.99K

--27.66K

--231.39K

--63.06K

--433.74K

Depreciation, depletion, and amortization

55.74%22.83K

78.76%19.68K

95.00%16.80K

52.95%15.95K

13.64%14.66K

-14.79%11.01K

-38.80%8.61K

--10.43K

47.72%12.90K

64.50%12.92K

76.95%14.08K

--8.73K

--7.85K

--7.96K

--7.91K

Other operating expenses

----

---61.64K

----

Operating profit

-9.76%-2.33M

61.69%-1.60M

-43.50%-1.91M

-9.59%-2.08M

-39.23%-2.12M

-431.57%-4.19M

-40.08%-1.33M

---1.89M

-607.41%-1.52M

-14.71%-788.00K

-480.69%-950.66K

---215.12K

---686.92K

---163.71K

---481.89K

Net non-operating interest income (expenses)

Non-operating interest expense

16.43%1.71K

-66.28%1.22K

27.67%1.79K

-73.89%1.42K

-96.34%1.47K

-99.67%3.62K

-99.88%1.40K

--5.45K

-96.70%40.11K

21.44%1.10M

49.75%1.14M

--1.22M

--905.52K

--762.22K

--921.04K

Special income (expenses)

64.61%-21.10K

-12656.31%-140.45K

-99.71%5.11K

87.13%-17.07K

-101.03%-59.63K

99.92%-1.10K

442.41%1.73M

---132.60K

25910.02%5.81M

-188.09%-1.46M

---505.97K

---22.50K

---505.61K

--0.00

Other non-operating income (expenses)

61.42%31.55K

-33.62%13.07K

5.87%30.32K

421.90%44.90K

127.73%19.55K

2596.44%19.68K

4746.02%28.64K

---13.95K

-2322.26%-70.49K

101.41%730.00

-96.84%591.00

--3.17K

---51.71K

--18.73K

--38.18K

Income before tax

-7.25%-2.32M

58.47%-1.73M

-538.56%-1.88M

-0.16%-2.05M

-151.76%-2.16M

-24.83%-4.17M

116.48%428.05K

---2.05M

387.75%4.17M

-55.53%-3.34M

-186.32%-2.60M

---1.45M

---2.15M

---907.20K

---1.36M

Income tax

0.00%250.00

242.47%1.50K

0.00%63.00

-921.31%-501.00

296.83%250.00

595.24%438.00

0.00%63.00

--61.00

-74.80%63.00

--250.00

Income after tax

-7.25%-2.32M

58.44%-1.73M

-538.64%-1.88M

-0.13%-2.05M

-151.77%-2.16M

-24.84%-4.17M

116.48%427.99K

---2.05M

387.70%4.17M

-55.51%-3.34M

-186.25%-2.60M

---1.45M

---2.15M

---907.45K

---1.36M

Net income from continuous operations

-7.25%-2.32M

58.44%-1.73M

-538.64%-1.88M

-0.13%-2.05M

-151.77%-2.16M

-24.84%-4.17M

116.48%427.99K

---2.05M

387.70%4.17M

-55.51%-3.34M

-186.25%-2.60M

---1.45M

---2.15M

---907.45K

---1.36M

Other net gains and losses

--2.31M

----

--250.00

----

Net Income attributable to non-controlling interests

0.14%-712.00

18.15%-1.20K

69.74%-752.00

88.55%-3.89K

92.62%-713.00

79.09%-1.47K

-198.34%-2.48K

---33.93K

-204.41%-9.66K

-125.73%-7.04K

-47.74%2.53K

---3.17K

---3.12K

--4.83K

---3.99K

Net income attributable to controlling interests

-7.38%-2.44M

56.64%-1.86M

-738.12%-1.99M

-2.09%-2.18M

-155.77%-2.28M

-28.59%-4.29M

112.02%312.59K

---2.13M

381.98%4.08M

-55.41%-3.34M

-185.01%-2.60M

---1.45M

---2.15M

---912.28K

---1.36M

Preferred share dividend

9.89%128.10K

7.49%126.71K

0.23%118.16K

9.89%130.97K

14.81%116.57K

--117.88K

--119.18K

--101.54K

----

--0.00

----

Net income attributable to common shareholders

-7.38%-2.44M

56.64%-1.86M

-738.12%-1.99M

-2.09%-2.18M

-155.77%-2.28M

-28.59%-4.29M

112.02%312.59K

---2.13M

381.98%4.08M

-55.41%-3.34M

-185.01%-2.60M

---1.45M

---2.15M

---912.28K

---1.36M

Basic earnings per share

85.72%-0.67

94.03%-1.26

-183.91%-1.55

89.66%-2.28

-110.12%-4.66

41.18%-21.14

106.61%1.85

---22.02

395.24%46.04

-55.41%-35.94

-185.01%-28.01

---15.59

---23.13

---9.83

---14.66

Diluted earnings per share

85.72%-0.67

94.03%-1.26

-183.91%-1.55

89.66%-2.28

-110.12%-4.66

41.18%-21.14

106.61%1.85

---22.02

395.24%46.04

-55.41%-35.94

-185.01%-28.01

---15.59

---23.13

---9.83

---14.66

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

